GlassScriptPhysician profile
Semil B Mehta
NPI 1972596021
$8,873.47
in general payments reported to CMS, 2019-2025
14 companies · $7,908 in 2025
The $7,908 reported for 2025 was more than what 94% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.24 · 2020: $15.17 · 2021: $26.30 · 2022: $57.75 · 2023: $320 · 2024: $497 · 2025: $7,908.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,225 · Food and Beverage: $1,685 · Travel and Lodging: $804 · Education: $10.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,225.00 |
| Food and Beverage | $1,685.03 |
| Travel and Lodging | $804.12 |
| Education | $10.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $7,376.89 | 2023-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Astrazeneca Pharmaceuticals LP | $612.63 | 2019-2025 | Fasenra, Airsupra, Breztri |
| United Therapeutics Corporation | $431.22 | 2024-2025 | |
| Verona Pharma, INC. | $121.83 | 2025 | Ohtuvayre |
| Ethicon INC. | $56.88 | 2024 | Monarch Platform |
| Harmony Biosciences LLC | $53.27 | 2024-2025 | |
| 3b Medical, INC. | $39.02 | 2024 | Luna |
| Genentech USA, INC. | $38.00 | 2019 | |
| Axsome Therapeutics, INC. | $32.73 | 2025 | Sunosi |
| Insmed, INC. | $30.92 | 2025 | Arikayce |
| Covis Pharma Gmbh | $25.70 | 2022 | |
| Shionogi INC | $21.50 | 2025 | Fetroja |
| Electromed, INC. | $18.96 | 2022 | |
| Philips North America LLC | $13.92 | 2025 | Patient Interface Software |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Semil Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.